↓ Skip to main content

Cochrane Database of Systematic Reviews

Oxycodone for pain in fibromyalgia in adults

Overview of attention for article published in Cochrane database of systematic reviews, September 2016
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (54th percentile)

Mentioned by

policy
1 policy source
twitter
13 tweeters
facebook
1 Facebook page
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
16 Dimensions

Readers on

mendeley
158 Mendeley
Title
Oxycodone for pain in fibromyalgia in adults
Published in
Cochrane database of systematic reviews, September 2016
DOI 10.1002/14651858.cd012329
Pubmed ID
Authors

Helen Gaskell, R Andrew Moore, Sheena Derry, Cathy Stannard

Abstract

This review replaces part of an earlier review that evaluated oxycodone for both neuropathic pain and fibromyalgia, which has now been split into separate reviews for the two conditions. This review will consider pain in fibromyalgia only.Opioid drugs are commonly used to treat fibromyalgia, but they may not be beneficial for people with this condition. Most reviews have examined all opioids together. This review sought evidence specifically for oxycodone, at any dose, and by any route of administration. To assess the analgesic efficacy and adverse events of oxycodone for treating pain in fibromyalgia in adults. We searched the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, and EMBASE for randomised controlled trials from inception to 25 July 2016. We also searched the reference lists of retrieved studies and reviews, and searched online clinical trial registries. We planned to include randomised, double-blind trials of eight weeks' duration or longer, comparing oxycodone (alone or in fixed-dose combination with naloxone) with placebo or another active treatment. We did not include observational studies. The plan was for two independent review authors to extract data and assess trial quality and potential bias. Where pooled analysis was possible, we planned to use dichotomous data to calculate risk ratio and numbers needed to treat for one additional event, using standard methods. No study satisfied the inclusion criteria. Effects of interventions were not assessed as there were no included studies. We have only very low quality evidence and are very uncertain about estimates of benefit and harm. There is no randomised trial evidence to support or refute the suggestion that oxycodone, alone or in combination with naloxone, reduces pain in fibromyalgia.

Twitter Demographics

The data shown below were collected from the profiles of 13 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 158 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 158 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 29 18%
Student > Bachelor 22 14%
Researcher 15 9%
Student > Doctoral Student 13 8%
Student > Ph. D. Student 12 8%
Other 24 15%
Unknown 43 27%
Readers by discipline Count As %
Medicine and Dentistry 51 32%
Nursing and Health Professions 19 12%
Psychology 12 8%
Pharmacology, Toxicology and Pharmaceutical Science 7 4%
Social Sciences 4 3%
Other 14 9%
Unknown 51 32%

Attention Score in Context

This research output has an Altmetric Attention Score of 15. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 February 2022.
All research outputs
#1,963,366
of 21,784,478 outputs
Outputs from Cochrane database of systematic reviews
#4,346
of 12,115 outputs
Outputs of similar age
#34,281
of 286,611 outputs
Outputs of similar age from Cochrane database of systematic reviews
#77
of 173 outputs
Altmetric has tracked 21,784,478 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,115 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 29.6. This one has gotten more attention than average, scoring higher than 64% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 286,611 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 173 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 54% of its contemporaries.